Loading company…
Sweden-based personalized cancer medicine company, founded in 2016, offering liquid biopsy testing and disease monitoring.
Based in Scania, Sweden, and founded in 2016 by COO Lao Saal and CTO Anthony George, SAGA Diagnostics AB develops personalized cancer medicine and disease monitoring technologies. Its tests quantify cancer-associated genetic changes in tissue and liquid biopsy samples, with detection limits down to 0.001% mutant allele fraction. In June 2021 it raised EUR 10.5 million in a Series A round co-led by Segulah and Sciety, with Hadean Ventures participating. Peter Collins is CEO as of January 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in